Low priced incentive drugs amounting to 620 billion won.

Published: 2005-05-02 06:56:00

Updated: 2005-05-02 06:56:00

The current provision describes that the pharmacist would be paid with about 30% balance from the expensive branded drugs when substituting for the incentive and cheaper drugs. The total value of such incentive and low priced drugs estimated to 620 billion won as of the end of 2004.

According...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK